The MIND-TD Faculty have been compensated by Neurocrine Biosciences, Inc.
Guidelines and Consensus on Screening and Treatment of Tardive Dyskinesia
Presentation
~2 mins
Oct 2022
1 of 6
Interactive
~5 mins
Dec 2022
Video
~3 mins
Nov 2022
By continuing to use this site, you agree to our use of cookies as described in our Cookie Policy.
This site contains information intended only for US healthcare professionals involved in the management of people with tardive dyskinesia.
This website is part of a disease-awareness, non-CME program sponsored by Neurocrine Biosciences, Inc.